47045-MLI-H-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Strengthening of the National Response to HIV/AIDS in Mali - Mali (01-Jan-2016-31-Dec-2017)</narrative> Mali, HIV, United Nations Development Programme Goals: Halve mortality in adults living with HIV by 2018 (from 13.52 deaths related to HIV / AIDS per 100 000 population in 2014 to 8.74 in 2017); Halve new infections in adults and children exposed to HIV by 2017. Objectives: By 2017, 65% reduction of the rate of mother to child transmission among children born to HIV-infected pregnant women is expected; By 2017, at least 90% of adults and children with HIV survive after 12 months on antiretroviral treatment; By 2017, screen for HIV and treat with antiretroviral at least 90% of patients coinfected with TB/HIV. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Mali HIV Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 29230806.53 Global Fund commitment to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 16678519.55 Global Fund disbursement to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 10738787.30 Global Fund disbursement to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -1813499.67 Global Fund commitment to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 9147632.68 Global Fund commitment to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 8322583.90 Global Fund disbursement to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2047404.45 Funds returned to the Global Fund from MLI-H-UNDPP01. United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -2047404.45 Global Fund commitment to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -825048.78 Global Fund commitment to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 282687.18 Funds returned to the Global Fund from MLI-H-UNDPP01. United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -282687.18 Global Fund commitment to MLI-H-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 2362; Denominator: 6195. Numerator: 1971; Denominator: 6065. Numerator: 3942; Denominator: 6065. Numerator: 1640; Denominator: 6065. Numerator: 1849; Denominator: 5690. Numerator: 724; Denominator: 5690. Numerator: 3699; Denominator: 5690. Numerator: 1541; Denominator: 5690. <narrative>Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth</narrative> Module: PMTCT. <narrative>Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 824; Denominator: 6195. Numerator: 607; Denominator: 6065. Numerator: 1213; Denominator: 6065. Numerator: 783; Denominator: 6065. Numerator: 1138; Denominator: 5690. Numerator: 295; Denominator: 5690. Numerator: 2276; Denominator: 5690. Numerator: 677; Denominator: 5690. <narrative>Percentage of pregnant women who know their HIV status</narrative> Module: PMTCT. <narrative>Percentage of pregnant women who know their HIV status</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 160412; Denominator: 866951. Numerator: 139574; Denominator: 930495. Numerator: 372198; Denominator: 930495. Numerator: 250581; Denominator: 930495. Numerator: 240998; Denominator: 963993. Numerator: 143252; Denominator: 963993. Numerator: 530196; Denominator: 963993. Numerator: 299947; Denominator: 963993. <narrative>Number of women and men aged 15+ who received an HIV test and know their results</narrative> Module: Prevention programs for general population. <narrative>Number of women and men aged 15+ who received an HIV test and know their results</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 104472. Numerator: 122330. Numerator: 244659. Numerator: 86574; Percentage: 35%. Numerator: 146030. Numerator: 44137; Denominator: 146030; Percentage: 30.2%. Numerator: 292059. Numerator: 103522; Denominator: 292059; Percentage: 35.4%. <narrative>M&E-other 1a : Percentage of PMTCT sites submitting timely reports on routine data</narrative> Module: RSSH: Health management information systems and M&E. <narrative>M&E-other 1a : Percentage of PMTCT sites submitting timely reports on routine data</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 151; Denominator: 416. Numerator: 208; Denominator: 416. Numerator: 312; Denominator: 416. Numerator: 501; Denominator: 684. Numerator: 374; Denominator: 416. Numerator: 403; Denominator: 680. Numerator: 416; Denominator: 416. Numerator: 457; Denominator: 680. <narrative>M&E-other 1b : Percentage of PMTCT sites submitting complete reports on routine data</narrative> Module: RSSH: Health management information systems and M&E. <narrative>M&E-other 1b : Percentage of PMTCT sites submitting complete reports on routine data</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 348; Denominator: 416. Numerator: 416; Denominator: 416. Numerator: 476; Denominator: 476. Numerator: 648; Denominator: 684. Numerator: 476; Denominator: 476. Numerator: 680; Denominator: 684. Numerator: 476; Denominator: 476. Numerator: 680; Denominator: 684. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 315; Denominator: 1050. Numerator: 740; Denominator: 1234. Numerator: 740; Denominator: 1234. Numerator: 1274; Denominator: 1354. Numerator: 864; Denominator: 1234. Numerator: 1532; Denominator: 1576. Numerator: 864; Denominator: 1234. Numerator: 1616; Denominator: 2018. <narrative>Percentage of health facilities reporting no stock-outs of essential drugs</narrative> Module: RSSH: Health products management systems. <narrative>Percentage of health facilities reporting no stock-outs of essential drugs</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 35; Denominator: 64. Numerator: 77; Denominator: 85. Numerator: 96; Denominator: 96. Numerator: 87; Denominator: 91. Numerator: 96; Denominator: 96. Numerator: 91; Denominator: 93. Numerator: 107; Denominator: 107. Numerator: 93; Denominator: 95. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 6776; Denominator: 42228. Numerator: 8418; Denominator: 51029. Numerator: 11225; Denominator: 56123. Numerator: 13812; Denominator: 53095. Numerator: 18365; Denominator: 61216. Numerator: 14895; Denominator: 47443. Numerator: 30608; Denominator: 61216. Numerator: 20284; Denominator: 44501. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 284; Denominator: 348. Numerator: 202; Denominator: 210. Numerator: 218; Denominator: 225. Numerator: 213; Denominator: 228. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 2570; Denominator: 5976. Numerator: 1983; Denominator: 3476. Numerator: 2067; Denominator: 3230. Numerator: 2267; Denominator: 3248. <narrative>Percentage of health facilities dispensing antiretroviral therapy that experienced a stock-out of at least one required antiretroviral drug in the last 12 month</narrative> Module: Treatment, care and support. <narrative>Percentage of health facilities dispensing antiretroviral therapy that experienced a stock-out of at least one required antiretroviral drug in the last 12 month</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 29; Denominator: 64. Numerator: 9; Denominator: 85. Numerator: 0; Denominator: 96. Numerator: 23; Denominator: 66. Numerator: 0; Denominator: 96. Numerator: 23; Denominator: 37. Numerator: 0; Denominator: 107. Numerator: 17; Denominator: 75. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 31472; Denominator: 79488. Numerator: 38131; Denominator: 81645. Numerator: 40823; Denominator: 81645. Numerator: 37902; Denominator: 81645. Numerator: 44898; Denominator: 81621. Numerator: 39721; Denominator: 81621. Numerator: 48973; Denominator: 81621. Numerator: 42078; Denominator: 81621. <narrative>TCS-other 1: Percentage of adults and children living with HIV who receive care (including ART)</narrative> Module: Treatment, care and support. <narrative>TCS-other 1: Percentage of adults and children living with HIV who receive care (including ART)</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 42237; Denominator: 89953. Numerator: 47664; Denominator: 88960. Numerator: 51029; Denominator: 88960. Numerator: 53095; Denominator: 88960. Numerator: 56123; Denominator: 87879. Numerator: 47556; Denominator: 87879. Numerator: 61216; Denominator: 87879. Numerator: 44501; Denominator: 87879.